THIS MESSAGE (MATERIAL) IS CREATED AND (OR) DISTRIBUTED BY A FOREIGN MASS MEDIA PERFORMING THE FUNCTIONS OF A FOREIGN AGENT AND (OR) A RUSSIAN LEGAL ENTITY PERFORMING THE FUNCTIONS OF A FOREIGN AGENT.
In the doping test of Russian figure skater Kamila Valieva, in addition to the banned drug trimetazidine, traces of two more heart drugs allowed for athletes were found, writes The New York Times, citing a document submitted as part of the trial in the case. The content of the document was confirmed to the publication by a source who participated in the hearings.
The doping test, in which traces of trimetazidine were found in an insignificant amount, was handed over in December 2021. According to the newspaper, a laboratory in Stockholm that analyzed a sample taken in December 2021 found traces of hypoxen and L-carnitine in it. They are authorized cardiac drugs and Valieva has reported on them in the relevant documents.
“These are three substances, two of which are allowed and one is not,” said Travis Tygart, Executive Director of the American Anti-Doping Agency (USADA), also noted that “three substances were found in the sample, two of which are allowed, and one is No”.
Recall, on the eve of the International Olympic Committee (IOC) published Valieva’s version of why her doping test gave a positive result. “She argued that the infection was due to the drug that her grandfather took,” said Denis Oswald, head of the IOC disciplinary commission.
Source: Rosbalt
Tristin is an accomplished author and journalist, known for his in-depth and engaging writing on sports. He currently works as a writer at 247 News Agency, where he has established himself as a respected voice in the sports industry.
